The tumor volume-time profiles were used to fit the CD8+ T cell proliferation half-life, maximum rate of ADCC, tumor cell apoptosis rate, maximum rate of CD8+ T cell influx, CTL-mediated tumor cell killing rate, tumor cell proliferation rate, and tumor carrying capacity (Supplementary Table S1). The gene discussed is CD8A; the disease is neoplasm.